1. The dark side of lipid metabolism in prostate and renal carcinoma: novel insights into molecular diagnostic and biomarker discovery
   Nicola Antonio di Meo et al, 2023, Expert Review of Molecular Diagnostics CrossRef
2. PI3K/Akt signaling in urological cancers: Tumorigenesis function, therapeutic potential, and therapy response regulation
   Sahar Rezaei et al, 2023, European Journal of Pharmacology CrossRef
3. MeCP2-Induced Alternations of Transcript Levels and m6A Methylation in Human Retinal Pigment Epithelium Cells
   Xueru Zhao et al, 2023, ACS Omega CrossRef
4. Genome-Wide Identification and Comparative Analysis of Elongation of Very Long-Chain Fatty Acid (Elovl) Genes in Echinoderms
   M.-Y. Liu et al, 2024, Russian Journal of Genetics CrossRef
5. ELOVL2 restrains cell proliferation, migration, and invasion of prostate cancer via regulation of the tumor suppressor INPP4B
   Tengfei Hu et al, 2022, Cellular Signalling CrossRef
6. Exploring the dual role of endoplasmic reticulum stress in urological cancers: Implications for tumor progression and cell death interactions
   Najma Farahani et al, 2024, Journal of Cell Communication and Signaling CrossRef
7. Identification of critical prognosis signature associated with lymph node metastasis of stomach adenocarcinomas
   Xiaohui Wang et al, 2023, World Journal of Surgical Oncology CrossRef
8. Fatty acids in cancer: Metabolic functions and potential treatment
   Ao Du et al, 2023, MedComm – Oncology CrossRef
9. Multiphase CT radiomics nomogram for preoperatively predicting the WHO/ISUP nuclear grade of small (< 4 cm) clear cell renal cell carcinoma
   Yankun Gao et al, 2023, BMC Cancer CrossRef
10. ELOVL5‐mediated fatty acid elongation promotes cellular proliferation and invasion in renal cell carcinoma
    Satoshi Nitta et al, 2022, Cancer Science CrossRef
11. Lipids as mediators of cancer progression and metastasis
    Felix C. E. Vogel et al, 2024, Nature Cancer CrossRef
12. The emerging role of long non-coding RNAs in renal cell carcinoma progression and clinical therapy via targeting metabolic regulation
    Xingyu Gao et al, 2023, Frontiers in Pharmacology CrossRef
13. Expression of decitabine-targeted oncogenes in meningiomas in vivo
    Julian Canisius et al, 2022, Neurosurgical Review CrossRef
14. Genome Editing Approaches with CRISPR/Cas9 for Cancer Treatment: Critical Appraisal of Preclinical and Clinical Utility, Challenges, and Future Research
    Sergiu Chira et al, 2022, Cells CrossRef
15. Ten Years of CRISPRing Cancers In Vitro
    Davide Capoferri et al, 2022, Cancers CrossRef
16. Renal Cell Carcinoma as a Metabolic Disease: An Update on Main Pathways, Potential Biomarkers, and Therapeutic Targets
    Nicola Antonio di Meo et al, 2022, International Journal of Molecular Sciences CrossRef